title: Increase of retinal nerve fiber layer thickness in ocular hypertensives with timolol therapy.
abstract: OBJECTIVE
  The purpose of this study was to determine whether timolol drops compared to placebo drops had a significant effect on retinal nerve fiber layer thickness in ocular hypertensives.
  
  
  METHODS
  Thirty-seven ocular hypertensives were randomly assigned to receive placebo or 0.5% timolol drops to both eyes for 18 to 24 months in a double masked clinical trial. Measurements of ocular pressure and photographs of retinal nerve fiber layer using stereophotogrammetric techniques were made at about 3 month intervals for 18 to 24 months of follow-up.
  
  
  RESULTS
  None of the subjects developed visual field loss when tested with the Goldmann perimeter by kinetic and static means at six month intervals. Subjects treated with timolol had a significant decrease in ocular pressure and developed a significant increase in retinal nerve fiber layer thickness compared to subjects treated with placebo. Multivariate analyses indicated that the increase of retinal nerve layer thickness was not associated either with the ocular pressure on treatment or the decrease in ocular pressure on treatment.
  
  
  CONCLUSIONS
  Timolol treatment was associated with an increase of retinal nerve fiber thickness. The effect of timolol appears to be related to mechanisms other than the decrease in ocular pressure.
authors.affiliation: Tufts University School of Medicine, Boston, Massachusetts, USA.
authors.forename: B
authors.initials: B
authors.lastname: Schwartz
authors.forename: T
authors.initials: T
authors.lastname: Takamoto
authors.forename: P
authors.initials: P
authors.lastname: Lavin
authors.forename: G
authors.initials: G
authors.lastname: Smits
mesh_terms: D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008954:Models, Biological; D015999:Multivariate Analysis; D009798:Ocular Hypertension / Q000188:drug therapy* / Q000473:pathology*; D012160:Retina / Q000187:drug effects* / Q000473:pathology*; D013999:Timolol / Q000627:therapeutic use*
chemical_list: D013999:Timolol